Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.754

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 47. Issue. 4

8488

Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)

Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia

Hematol Transfus Cell Ther. 2025;47:103822

8488

Full text access

Share

5081

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies

Tomasz Sacha, Katarzyna Krawczyk

Hematol Transfus Cell Ther. 2025;47:103675

5081

Full text access

Share

4694

Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?

Daniel Mazza Matos

Hematol Transfus Cell Ther. 2025;47:103668

4694

Full text access

Share

4455

When innovation meets patient blood management – a new way to see bleeding

Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene

Hematol Transfus Cell Ther. 2025;47:103691

4455

Full text access

Share

4344

An approach to autologous stem cell mobilization: trying to define good mobilizers

Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña

Hematol Transfus Cell Ther. 2025;47:103688

4344

Full text access

Share

3829

Optimization of hydroxyurea in sickle cell disease in Brazil

Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado

Hematol Transfus Cell Ther. 2025;47:103826

3829

Full text access

Share

3797

Blood storage effect of G6PD on RBC quality

Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank

Hematol Transfus Cell Ther. 2025;47:103733

3797

Full text access

Share

3580

From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy

Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo

Hematol Transfus Cell Ther. 2025;47:103693

3580

Full text access

Share

3213

Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?

Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo

Hematol Transfus Cell Ther. 2025;47:103687

3213

Full text access

Share

3112

Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review

Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues

Hematol Transfus Cell Ther. 2025;47:103849

3112

Full text access

Share

2906

Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles

Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza

Hematol Transfus Cell Ther. 2025;47:103727

2906

Full text access

Share

2790

Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review

Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira

Hematol Transfus Cell Ther. 2025;47:103736

2790

Full text access

Share

2702

Complex somatic mutation landscape in myeloid cells in a patient with VEXAS syndrome: First Brazilian case report

Fabíola Reis de Oliveira, Adriane Souza Lima, Carlos Roberto Faria, Thaise Oliveira Quaresma, Marcio M. Mourani, Lauro Wichert-Ana, Paulo Louzada, Fernanda Gutierrez-Rodrigues, ... Rodrigo T. Calado

Hematol Transfus Cell Ther. 2025;47:103686

2702

Full text access

Share

2687

Lower doses of dacarbazine (modified BEACODD) as a safer strategy with equal effectiveness in an intensive treatment protocol of Hodgkin's lymphoma: a preliminary retrospective analysis of a single public center in Brazil

Larissa Hilario Dulley, Arthur Gomes Oliveira Braga, Guilherme Garcia Rodrigues, Sergio Costa Fortier, Carlos Sérgio Chiattone, Talita Maira Bueno da Silveira

Hematol Transfus Cell Ther. 2025;47:103682

2687

Full text access

Share

2619

Impact of blueberry extract on hematological response in phenylhydrazine-induced hemolytic anemia

Daniela Drosdowski, Patrick Türck, Silvio Tasca, Gabriel de Lima Rosa, Edson Fernando Muller Guzzo, Sara Elis Bianchi, Adriana Simon Coitinho, Cristina Campos Carraro, ... Alex Sander da Rosa Araujo

Hematol Transfus Cell Ther. 2025;47:103744

2619

Full text access

Share

2613

STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy

Indranil Dey, Sushant Vinarkar, Mayur Parihar, Deepak Kumar Mishra

Hematol Transfus Cell Ther. 2025;47:103726

2613

Full text access

Share

2487

Overall survival in multiple myeloma in Brazil: A cohort of 16 years

Deborah Marta do Santos Oliveira, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, Isabella Zuppo Laper, Pâmela Santos Azevedo, Adriano de Paula Sabino, Marisa Yurico Itonaga, Carmino Antonio de Souza, ... Augusto Afonso Guerra Junior

Hematol Transfus Cell Ther. 2025;47:103962

2487

Full text access

Share

2395

A IMPORTÂNCIA DO PROGRAMA DE EDUCAÇÃO PELO TRABALHO PARA A SAÚDE EQUIDADE NA ATENÇÃO PRIMÁRIA: REFLEXÕES SOBRE CUIDADO À SAÚDE DA POPULAÇÃO NEGRA COM DOENÇA FALCIFORME

JVS Valadares, ARM Oliveira, MLB Neto, TM Peixoto, CC Lima, CFS Silva, VFA Santos, VSC Lima, ... NBA Miranda

Hematol Transfus Cell Ther. 2025;47 Supl 3:104009

2395

Full text access

Share

2362

Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis

Luana Joana Barreto Cabral, Daniela Pereira Lopes, Eduardo dos Santos Martins Filho, Rubenilson Caldas Valois, Paula Christine Amarantes Justino Oliveira, Patrícia Jeanne de Souza Mendonça-Mattos

Hematol Transfus Cell Ther. 2025;47:103821

2362

Full text access

Share

2249

Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis

Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran

Hematol Transfus Cell Ther. 2025;47:103737

2249

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics